An experienced team delivering anti-cancer therapeutics with breakthrough potential
Karus Therapeutics is a clinical-stage biopharmaceutical company. We are developing precision medicines for cancer.
Our highly experienced management team has a track record of scientific and clinical excellence in small-molecule drug design and development. Our programs are underpinned by a broad, wholly-owned, intellectual property estate.
Our orally-active small-molecule drugs have been designed and developed to be highly-selective therapies for cancer patients with unmet medical needs and limited treatment options.
We have two small molecule clinical candidates in Phase I studies, KA2507 and KA2237. By end-2019 we are planning to progress these to Phase II clinical trials. Pre-clinical data show that our innovative small-molecules have the potential to be used in combination with other therapies for the treatment of solid tumors and hematological cancers.
We invest in research and development of the highest quality and collaborate with leading academic centers of excellence. Our R&D program is focused on a new generation of brain-penetrant, non-genotoxic molecules targeting glioblastoma and other indications.
We seek strategic collaborations with leading companies who are commercializing innovative anti-cancer therapeutics.
Phase I clinical trials for KA22507 (NCT03008018) and KA2237 (NCT02679196) are currently underway in collaboration with The University of Texas MD Anderson Cancer Center.
We are supported by a syndicate of world-class life science investors from the US and Europe.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Google Analytics Cookies
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visist to our site you can disable tracking in your browser here:
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: